Fovinaciclib

DB21721InvestigationalSmall molecule

Fovinaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Fovinaciclib is a cyclin dependant kinase inhibitor. Fovinaciclib has a monoisotopic molecular...

Mechanism: Pharmacologically active on Cyclin-dependent kinase 6 and Cyclin-dependent kinase 4
Curator reviewed
Formula / weight: C₂₉H₄₀N₈OS · 548.75 g/mol (avg)

Resolves to

Compound

UNIILPW3H579X8CAS2146171-49-3ChEMBLCHEMBL6068012ChEBI759930PubChem132136461

Structure

InChIKeyPGGPKYATZSPYKB-UHFFFAOYSA-NSMILESCN(C)C(=O)C1=C(C2CCCC2)C2=NC(NC3=CC=C(C=N3)N3CCC(CC3)N3CCN(C)CC3)=NC=C2S1

Targets

Q00534CDK6P11802CDK4

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fovinaciclib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account